Hypertension in Athletes: Clinical Implications and Management Strategies.
| Autor: | Tso JV; Division of Cardiology, Emory University School of Medicine, 101 Woodruff Circle, WMB 319, Atlanta, GA 30322, USA. Electronic address: https://twitter.com/jasontsomd., Kim JH; Division of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, 1462 Clifton Road, Northeast, Suite 502, Atlanta, GA 30322, USA. Electronic address: jonathan.kim@emory.edu. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cardiac electrophysiology clinics [Card Electrophysiol Clin] 2024 Mar; Vol. 16 (1), pp. 15-24. |
| DOI: | 10.1016/j.ccep.2023.09.004 |
| Abstrakt: | Hypertension is a leading cardiovascular risk factor in athletes. Sport-specific behaviors including nonsteroidal anti-inflammatory use, stimulant use, and unhealthy diets may promote hypertension among athletes. Strength-trained athletes may be more susceptible to hypertension than endurance-trained athletes, although this may, in part, be due to body size differences and the more potent antihypertensive effects of aerobic exercise. With confirmed hypertension, young athletes require secondary hypertension evaluation while older athletes require full cardiovascular risk stratification. Calcium channel blockers and renin-angiotensin-system inhibitors are often preferred pharmacotherapy agents. Further selection of antihypertensives must include consideration of potential side effects and legality in specific sports. Competing Interests: Disclosure Dr J.H. Kim receives compensation serving in his role as team cardiologist for the Atlanta Falcons. Dr J.V. Tso reports no disclosures. (Copyright © 2023 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|